Quarterly Call Option Transactions in Spdr Ser Tr Spdr S&P Biotech E (XBI)
This table provides information about the institutional ownership of Spdr Ser Tr Spdr S&P Biotech E (XBI) during . The information is specifically focused on institutions that hold call options of SPDR SER TR SPDR S&P BIOTECH E.
Calls Purchased
Calls Sold
| Quarter | Buy | Sell | Net Activity | |||||
|---|---|---|---|---|---|---|---|---|
| New Holding | Increment | Total Shares Bought | Closed Position | Reduction | Total Shares Sold | |||
| Q3 2021 | 1,638,600 | 5,147,788 | 6,786,388 | 1,914,100 | 1,132,417 | 3,046,517 | 3,739,871 | |
| Q4 2021 | 5,803,640 | 9,276,100 | 15,079,740 | 1,775,800 | 4,446,700 | 6,222,500 | 8,857,240 | |
| Q1 2022 | 6,905,160 | 10,964,600 | 17,869,760 | 4,442,953 | 2,475,300 | 6,918,253 | 10,951,507 | |
| Q2 2022 | 4,178,111 | 1,636,139 | 5,814,250 | 7,543,200 | 3,785,900 | 11,329,100 | -5,514,850 | |
| Q3 2022 | 6,279,500 | 6,087,600 | 12,367,100 | 4,521,939 | 0 | 4,521,939 | 7,845,161 | |
| Q4 2022 | 682,700 | 5,156,100 | 5,838,800 | 4,556,211 | 0 | 4,556,211 | 1,282,589 | |
| Q1 2023 | 1,261,211 | 4,072,500 | 5,333,711 | 5,128,600 | 2,300 | 5,130,900 | 202,811 | |
| Q2 2023 | 2,166,625 | 3,183,300 | 5,349,925 | 2,233,800 | 0 | 2,233,800 | 3,116,125 | |
| Q3 2023 | 1,878,575 | 3,297,500 | 5,176,075 | 1,403,900 | 0 | 1,403,900 | 3,772,175 | |
| Q4 2023 | 7,653,200 | 1,769,870 | 9,423,070 | 784,000 | 0 | 784,000 | 8,639,070 | |
| Q1 2024 | 2,971,500 | 4,516,300 | 7,487,800 | 5,229,550 | 0 | 5,229,550 | 2,258,250 | |
| Q2 2024 | 3,099,900 | 1,709,901 | 4,809,801 | 7,039,300 | 0 | 7,039,300 | -2,229,499 | |
| Q3 2024 | 6,705,300 | 9,265,650 | 15,970,950 | 4,648,200 | 0 | 4,648,200 | 11,322,750 | |